USP32 (ubiquitin specific peptidase 32)
| Gene | |
|
Entrez ID
Entrez Gene ID - the GENE ID in NCBI Gene database.
|
84669 |
|
Gene name
Gene Name - the full gene name approved by the HGNC.
|
Ubiquitin specific peptidase 32 |
|
Gene symbol
Gene Symbol - the official gene symbol approved by the HGNC.
|
USP32 |
|
Synonyms (NCBI Gene)
Gene synonyms aliases
|
NY-REN-60, USP10 |
|
Chromosome
Chromosome number
|
17 |
|
Chromosome location
Chromosomal Location - indicates the cytogenetic location of the gene or region on the chromosome.
|
17q23.1-q23.2 |
|
miRNA
miRNA information provided by mirtarbase database.
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
Gene ontology (GO)
Gene ontology information of associated ontologies with gene provided by GO database.
|
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
|
Other IDs
Other ids provides unique ids of gene in databases such as OMIM, HGNC, ENSEMBLE.
|
|||||||
|
|||||||
| Protein | ||||||||||||||||||||||||||
| UniProt ID | Q8NFA0 | |||||||||||||||||||||||||
| Protein name | Ubiquitin carboxyl-terminal hydrolase 32 (EC 3.4.19.12) (Deubiquitinating enzyme 32) (Renal carcinoma antigen NY-REN-60) (Ubiquitin thioesterase 32) (Ubiquitin-specific-processing protease 32) | |||||||||||||||||||||||||
| Protein function | Deubiquitinase that can remove conjugated ubiquitin from target proteins, such as RAB7A and LAMTOR1 (PubMed:36476874). Acts as a positive regulator of the mTORC1 signaling by mediating deubiquitination of LAMTOR1, thereby promoting the associati | |||||||||||||||||||||||||
| Family and domains |
Pfam
|
|||||||||||||||||||||||||
| Sequence | ||||||||||||||||||||||||||
| Sequence length | 1604 | |||||||||||||||||||||||||
| Interactions | View interactions | |||||||||||||||||||||||||
|
Associated diseases
Disease associations categorized as Causal (pathogenic variants), Unknown (uncertain genetic evidence), or Text Mining (literature-based associations)
|
|||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||